Please use this identifier to cite or link to this item: https://open.uns.ac.rs/handle/123456789/8462
DC FieldValueLanguage
dc.contributor.authorVavić N.en_US
dc.contributor.authorRančić N.en_US
dc.contributor.authorDragojević-Simić V.en_US
dc.contributor.authorDrašković-Pavlović B.en_US
dc.contributor.authorBokonjić D.en_US
dc.contributor.authorIgnjatović L.en_US
dc.contributor.authorMomir Mikoven_US
dc.date.accessioned2019-09-30T09:08:52Z-
dc.date.available2019-09-30T09:08:52Z-
dc.date.issued2014-01-01-
dc.identifier.issn3787966en_US
dc.identifier.urihttps://open.uns.ac.rs/handle/123456789/8462-
dc.description.abstract© 2013 Springer-Verlag France. Tacrolimus is an immunosuppressant used for the prevention of kidney allograft rejection. The effects of comedication on tacrolimus trough concentrations (TTC) in kidney transplant recipients, subjected to basic immunosuppressant regime consisting of tacrolimus, corticosteroids and mycophenolate mofetil were investigated. This retrospective case series study involved 208 of these patients, with the outpatient examination recorded in the database of patients, at the unit of monitoring, with a total of 5,011 such examinations. Binary logistic regression analysis has shown that calcium channel blockers, diuretics and proton pump inhibitors (PPIs) significantly affected TTC (p < 0.001). PPIs significantly increased the number of examinations in which the TTC were in the recommended therapeutic range (from 5 to 15 ng/ml), as well as over the therapeutic range (p < 0.0001). When calcium channel blockers were added to PPIs, even more pronounced effect was obtained in comparison to triple-drug therapy only (p < 0.0001). In case a diuretic was given with a PPI, a significantly increased number of examinations with subtherapeutic TTC was observed when compared with PPI only (p = 0.0203). The combination of calcium channel blockers, diuretics and PPIs resulted in the number of examinations with TTC in the recommended therapeutic range not being different from the number of examinations with TTC in the triple-drug therapy only (p = 0.3829). β-adrenergic antagonists can be administered without fear of affecting the tacrolimus optimal therapeutic concentrations. This was confirmed with all combinations of the examined drugs used in patients subjected to kidney transplantation concomitantly with β blockers.en_US
dc.language.isoenen_US
dc.relation.ispartofEuropean Journal of Drug Metabolism and Pharmacokineticsen_US
dc.subjectTacrolimusen_US
dc.subjectKidney transplantationen_US
dc.subjectComedicationen_US
dc.subjectTherapeutic drug monitoringen_US
dc.subjectDrug interactionsen_US
dc.titleThe influence of comedication on tacrolimus blood concentration in patients subjected to kidney transplantation: A retrospective studyen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.doi10.1007/s13318-013-0168-3-
dc.identifier.pmid39-
dc.identifier.scopus2-s2.0-84890394469-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/84890394469-
dc.description.versionPublisheden_US
dc.relation.lastpage253en_US
dc.relation.firstpage243en_US
dc.relation.issue4en_US
dc.relation.volume39en_US
item.grantfulltextnone-
item.fulltextNo Fulltext-
Appears in Collections:MDF Publikacije/Publications
Show simple item record

SCOPUSTM   
Citations

15
checked on May 10, 2024

Page view(s)

15
Last Week
0
Last month
0
checked on May 10, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.